We are live on ! Find out more
PA

PharVision Advisers Portfolio holdings

AUM $9.86M
1-Year Est. Return 9.93%
This Fund
S&P 500
This Quarter Est. Return
+7.62%
1 Year Est. Return
+9.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$178M
AUM Growth
+$108M
Cap. Flow
+$107M
Cap. Flow %
60.42%
Top 10 Hldgs %
3.93%
Holding
829
New
562
Increased
57
Reduced
34
Closed
175

Top Buys

Rank Stock Value
1
SFM icon
Sprouts Farmers Market
SFM
+$969K
2
TIGR
UP Fintech Holding
TIGR
+$737K
3
CAAP icon
Corporacion America
CAAP
+$729K
4
LX
LexinFintech Holdings
LX
+$728K
5
W icon
Wayfair
W
+$720K

Top Sells

Rank Stock Value
1
CRUS icon
Cirrus Logic
CRUS
+$563K
2
MNST icon
Monster Beverage
MNST
+$526K
3
CLX icon
Clorox
CLX
+$510K
4
OKTA icon
Okta
OKTA
+$488K
5
NDSN icon
Nordson
NDSN
+$480K

Sector Composition

Rank Sector Weight
1 Technology 15.42%
2 Healthcare 13.97%
3 Financials 13.71%
4 Consumer Discretionary 13.67%
5 Industrials 13.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CPF icon
276
Central Pacific Financial
CPF
$1.01B
$276K 0.16%
+9,098
New +$266K
PFBC icon
277
Preferred Bank
PFBC
$1.23B
$275K 0.15%
+3,044
New +$282K
DDOG icon
278
Datadog
DDOG
$89.7B
$275K 0.15%
+1,930
New +$266K
OGE icon
279
OGE Energy
OGE
$10.2B
$275K 0.15%
5,939
+877
+17% +$39.3K
MLI icon
280
Mueller Industries
MLI
$14.2B
$275K 0.15%
5,432
-2,268
-29% -$104K
YUMC icon
281
Yum China
YUMC
$15.3B
$274K 0.15%
+6,393
New +$291K
GRPN icon
282
Groupon
GRPN
$1.05B
$273K 0.15%
+11,696
New +$336K
MIRM icon
283
Mirum Pharmaceuticals
MIRM
$6.96B
$273K 0.15%
+3,724
New +$237K
CDE icon
284
Coeur Mining
CDE
$15.8B
$273K 0.15%
14,546
+480
+3% +$5.88K
GH icon
285
Guardant Health
GH
$19.3B
$273K 0.15%
+4,366
New +$238K
FRSH icon
286
Freshworks
FRSH
$2.99B
$272K 0.15%
23,135
+9,253
+67% +$125K
COUR icon
287
Coursera
COUR
$1.61B
$272K 0.15%
+23,218
New +$252K
XPEV icon
288
XPeng
XPEV
$12.2B
$271K 0.15%
+11,585
New +$232K
OPCH icon
289
Option Care Health
OPCH
$3.42B
$271K 0.15%
+9,761
New +$283K
TNDM icon
290
Tandem Diabetes Care
TNDM
$1.18B
$270K 0.15%
+22,268
New +$301K
ARCO icon
291
Arcos Dorados Holdings
ARCO
$1.75B
$269K 0.15%
+39,854
New +$283K
RGP icon
292
Resources Connection
RGP
$133M
$268K 0.15%
+53,142
New +$273K
BIRK icon
293
Birkenstock
BIRK
$7.64B
$268K 0.15%
+5,929
New +$290K
IPG
294
DELISTED
Interpublic Group of Companies
IPG
$267K 0.15%
+9,584
New +$247K
HAPN
295
Happen Inc
HAPN
$2.16B
$267K 0.15%
+17,605
New +$267K
GTES icon
296
Gates Industrial Corporation Ltd.
GTES
$6.72B
$267K 0.15%
10,764
+1,759
+20% +$43.7K
MDGL icon
297
Madrigal Pharmaceuticals
MDGL
$12.7B
$267K 0.15%
+582
New +$217K
MMSI icon
298
Merit Medical Systems
MMSI
$4.54B
$265K 0.15%
+3,189
New +$278K
VMD icon
299
Viemed Healthcare
VMD
$465M
$265K 0.15%
+39,036
New +$264K
CXM icon
300
Sprinklr
CXM
$1.42B
$265K 0.15%
34,307
-13,984
-29% -$118K
10 11
12
13 14

Similar funds

BS
BCI Securities Miami, Florida $10.1M AUM
RG
Raine Group New York $10.5M AUM 23.14% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return
AIA
Acute Investment Advisory Mesa, Arizona $8.91M AUM 4.28% 1-Year Est. Return
CCM
Crabel Capital Management Los Angeles, California $10.8M AUM 3.34% 1-Year Est. Return
DFA
Davies Financial Advisors Murrieta, California $10.9M AUM 21.57% 1-Year Est. Return
CCP
Caden Capital Partners Santa Monica, California $8.12M AUM 16.97% 1-Year Est. Return
FRT
FTX Recovery Trust League City, Texas $11.8M AUM

PharVision Advisers's Q3 2025 Portfolio in Review

As of Q3 2025, PharVision Advisers held 829 positions worth $178M, up 155% from $69.6M the previous quarter. Its ten largest holdings account for 3.9% of the portfolio.

PharVision Advisers deployed $107M of net new capital in Q3 2025, opening 562 new positions and adding to 57 existing holdings. Its largest new stake was Sprouts Farmers Market: 6,658 shares worth $724K.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Western Union, an estimated $321K trimmed.

  • PharVision Advisers's largest Q3 2025 buy was Sprouts Farmers Market: 6,658 shares worth $724K.
  • PharVision Advisers added most to Gogo Inc in Q3 2025, an estimated $397K increase.
  • PharVision Advisers's biggest Q3 2025 reduction was Western Union, cutting an estimated $321K.
  • PharVision Advisers fully exited Cirrus Logic in Q3 2025, selling an estimated $563K.
  • PharVision Advisers's ten largest holdings make up 3.9% of its $178M portfolio in Q3 2025.
  • PharVision Advisers opened 562 new positions and closed 175 in Q3 2025.
  • PharVision Advisers's portfolio value rose 155% quarter-over-quarter to $178M.

Based on PharVision Advisers's 13F filing for Q3 2025, filed 17 Nov 2025.